Should the drug companies have their diagnostic clinics.

dc.contributor.authorJain, P Cen_US
dc.date.accessioned2003-10-01en_US
dc.date.accessioned2009-05-31T07:25:14Z
dc.date.available2003-10-01en_US
dc.date.available2009-05-31T07:25:14Z
dc.date.issued2003-10-01en_US
dc.identifier.citationJain PC. Should the drug companies have their diagnostic clinics. Journal of the Indian Medical Association. 2003 Oct; 101(10): 608en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/96871
dc.language.isoengen_US
dc.source.urihttps://www.jimaonline.org.in/en_US
dc.subject.meshConflict of Interesten_US
dc.subject.meshDrug Industryen_US
dc.subject.meshHealth Facilities, Proprietaryen_US
dc.subject.meshHumansen_US
dc.subject.meshIndiaen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.titleShould the drug companies have their diagnostic clinics.en_US
dc.typeLetteren_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: